(PharmaNewsWire.Com, October 04, 2017 ) ReportsWeb.com published “Radiation Injury - Pipeline Review H1 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Injury - Pipeline Review, H1 2017, provides an overview of the Radiation Injury (Toxicology) pipeline landscape.
Radiation injury is damage to tissues caused by exposure to ionizing radiation. Symptoms depend on whether radiation exposure involves the whole body or is limited to a small portion of the body. At high doses, whole-body exposure causes acute radiation illness, and partial-body exposure causes local radiation injury. For more information about this report: http://www.reportsweb.com/radiation-injury-pipeline-review-h1-2017 Publisher's Pharmaceutical and Healthcare latest pipeline guide Radiation Injury - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Radiation Injury (Toxicology) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Radiation Injury (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Preclinical, Discovery and Unknown stages are 1, 8, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively. Report Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Radiation Injury (Toxicology) . - The pipeline guide reviews pipeline therapeutics for Radiation Injury (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Radiation Injury (Toxicology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Radiation Injury (Toxicology) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Radiation Injury (Toxicology) Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001709471/sample - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Radiation Injury (Toxicology) . - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Radiation Injury (Toxicology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. List of Tables
Number of Products under Development for Radiation Injury, H1 2017 Number of Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Radiation Injury - Pipeline by Bristol-Myers Squibb Company, H1 2017 Radiation Injury - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017 Radiation Injury - Pipeline by Galena Biopharma Inc, H1 2017 Radiation Injury - Pipeline by Gilead Sciences Inc, H1 2017 Radiation Injury - Pipeline by Italfarmaco SpA, H1 2017 Radiation Injury - Pipeline by Karus Therapeutics Ltd, H1 2017 Radiation Injury - Pipeline by Nerviano Medical Sciences Srl, H1 2017 Radiation Injury - Pipeline by Novartis AG, H1 2017 Radiation Injury - Pipeline by PharmaEssentia Corp, H1 2017 Radiation Injury - Dormant Projects, H1 2017 Radiation Injury - Discontinued Products, H1 2017
List of Figures
Number of Products under Development for Radiation Injury, H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products by Top 10 Targets, H1 2017 Number of Products by Stage and Top 10 Targets, H1 2017 Number of Products by Top 10 Mechanism of Actions, H1 2017 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017 Number of Products by Routes of Administration, H1 2017 Number of Products by Stage and Routes of Administration, H1 2017 Number of Products by Molecule Types, H1 2017 Number of Products by Stage and Molecule Types, H1 2017 Inquire before Buying at http://www.reportsweb.com/buy&RW0001709471/buy/2000 Contact Us: Call: +1-646-491-9876 Email: sales@reportsweb.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
